FDA explains how to use secondary endpoints in clinical tria

The U.S. Food and Drug Administration (FDA) recently finalized the guidance “Multiple Endpoints in Clinical Trials,” which advises drug sponsors on…

Related Keywords

John Lawrence , Office Of Biostatistics , European Medicines Agency , International Council For Harmonisation , Drug Administration , Clinical Trials , International Council , Law , Lawyers , Legal , Aw Firms , Aw Updates , Egal Updates , Egal Developments , Aw Developments , Egal Newsletters , Egal Current Awareness , Deals , Egal Advisers , Egal Advisors , Egal Directory , Sa , Roduct Regulation Amp Liability ,